Kronox Lab Sciences had a decent listing at the bourses, falling short of expectations due to market volatility. Analysts praise its strong position in specialty fine chemicals sector.
Earnings downgrade cycle largely over, no major cuts expected from Q3 onwards: Pawan Parakh
I strongly believe that earnings misses have largely bottomed out in Q2. If we look at corporate India’s performance, two sectors have disappointed slightly. First